GNOM.L vs. WBIO.L
GNOM.L (Global X Genomics & Biotechnology UCITS ETF) and WBIO.L (WisdomTree BioRevolution UCITS ETF USD Acc) are both Health & Biotech Equities funds - GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF while WBIO.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 3 years, GNOM.L returned 4.58%/yr vs 6.27%/yr for WBIO.L. Their correlation of 0.90 suggests significant overlap in exposure. GNOM.L charges 0.50%/yr vs 0.45%/yr for WBIO.L.
Performance
GNOM.L vs. WBIO.L - Performance Comparison
Loading charts...
Different Trading Currencies
GNOM.L is traded in USD, while WBIO.L is traded in GBp. To make them comparable, the WBIO.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GNOM.L achieves a 22.10% return, which is significantly higher than WBIO.L's 19.99% return.
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
WBIO.L
- 1D
- 0.39%
- 1M
- 10.80%
- 6M
- 11.98%
- YTD
- 19.99%
- 1Y
- 52.30%
- 3Y*
- 6.27%
- 5Y*
- —
- 10Y*
- —
GNOM.L vs. WBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -4.38% |
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 19.99% | 22.15% | -15.51% | -0.89% | -26.98% | 0.33% |
Correlation
The correlation between GNOM.L and WBIO.L is 0.87, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.87 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.90 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 2021 | 0.90 |
The correlation between GNOM.L and WBIO.L has been stable across timeframes, ranging from 0.87 to 0.90 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM.L vs. WBIO.L — Risk / Return Rank
GNOM.L
WBIO.L
GNOM.L vs. WBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOM.L) and WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM.L | WBIO.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.24 | ||
| Sortino ratioReturn per unit of downside risk | +0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.30 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 4.05 | -0.70 |
| Martin ratioReturn relative to average drawdown | 9.16 | 9.58 | -0.42 |
Loading charts...
Drawdowns
GNOM.L vs. WBIO.L - Drawdown Comparison
The maximum GNOM.L drawdown since its inception was -69.32%, which is greater than WBIO.L's maximum drawdown of -53.23%. Use the drawdown chart below to compare losses from any high point for GNOM.L and WBIO.L.
Loading charts...
Drawdown Indicators
| GNOM.L | WBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.32% | -53.23% | -16.09% |
Max Drawdown (1Y)Largest decline over 1 year | -18.91% | -12.86% | -6.05% |
Max Drawdown (3Y)Largest decline over 3 years | -44.77% | -39.86% | -4.91% |
Current DrawdownCurrent decline from peak | -37.11% | -11.27% | -25.84% |
Average DrawdownAverage peak-to-trough decline | -47.16% | -29.42% | -17.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.92% | 5.44% | +1.48% |
Volatility
GNOM.L vs. WBIO.L - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a higher volatility of 8.41% compared to WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) at 7.28%. This indicates that GNOM.L's price experiences larger fluctuations and is considered to be riskier than WBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM.L | WBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 7.28% | +1.13% |
Volatility (6M)Calculated over the trailing 6-month period | 22.18% | 18.81% | +3.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.87% | 27.79% | +2.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.11% | 25.39% | +7.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.11% | 25.39% | +7.72% |
GNOM.L vs. WBIO.L - Expense Ratio Comparison
GNOM.L has a 0.50% expense ratio, which is higher than WBIO.L's 0.45% expense ratio.
Dividends
GNOM.L vs. WBIO.L - Dividend Comparison
Neither GNOM.L nor WBIO.L has paid dividends to shareholders.
Frequently Asked Questions
GNOM.L and WBIO.L have a correlation of 0.87, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WBIO.L is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WBIO.L is cheaper with a 0.45% expense ratio, compared with 0.50% for GNOM.L.
GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF, while WBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: Global X and WisdomTree. Their fees differ too: 0.50% for GNOM.L and 0.45% for WBIO.L.
Find the right allocation for GNOM.L and WBIO.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer